Fycompa · DIN 02404540 · 8 mg · tablet
Limited Use, Reason for Use code 430, 564 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 430, 564 required
Write on scriptone applicable Reason for Use code, 430 or 564 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 430, 564
Reason for Use code 430
As adjunctive therapy in the treatment of patients with partial onset seizures who have had an inadequate response or have significant intolerance to at least 3 less costly anticonvulsant therapies; AND
Patients are under the care of a physician experienced in the treatment of epilepsy.
Note: Less costly anticonvulsant therapies may include the following:
Phenytoin, Carbamazepine, Gabapentin, Lamotrigine, Vigabatrin, Topiramate, etc.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 564
For adjunctive therapy in the management of primary generalized tonic-clonic (PGTC) seizures in patients with epilepsy who have had an inadequate response or have significant intolerance to at least 3 less costly anticonvulsant therapies;
AND
Patients are under the care of a physician experienced in the treatment of epilepsy.
Note: Less costly anticonvulsant therapies may include the following:
Phenytoin, Carbamazepine, Gabapentin, Lamotrigine, Vigabatrin, Topiramate, etc.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Fycompa · DIN 02404540
Manufacturer: Eisai Limited; listing date 2014-02-27
Health Canada: Marketed since 2013-06-19 · brand FYCOMPA · ATC N03AX22 PERAMPANEL · form Tablet · route Oral · ingredients PERAMPANEL 8.0 MG · company Eisai limited · schedule Prescription
Ministry pays: $5.7128 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02404540)
Source record
DIN 02404540: Fycompa
Raw flags: sec12=Y, sec3=Y
Item: 281200164; group id 437; item number 1093; lccId 00240; manufacturer id EIS
Source form: Tab; strength: 8mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $10.3869; ministry $5.7128
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02404540
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88931
Interchangeable products
Taro-Perampanel · DIN 02522667 · $5.7128
Shortage status: not checked (no credentials)